跳至主要内容
临床试验/NL-OMON27861
NL-OMON27861已完成不适用

A randomized placebo-controlled study in patients with a Gallium-68 DOTATATE PET/CT positive, clinically non-functioning pituitary macroadenoma (NFMA) of the effect of Lanreotide autosolution on Tumor (adenoma) size (GALANT)

Prof. dr. E. Fliers, Academic Medical Center, University of Amsterdam0 个研究点目标入组 44 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
44

研究概览

研究设计

研究类型
Interventional

入排标准

入选标准

  • Adult patients (>18 yrs)
  • Clinically non-functioning pituitary macroadenoma with suprasellar extension

排除标准

  • Optic chiasm compression with visual field defects
  • Hypersensitivity for somatostatin or similar peptides

研究者

发起方
Prof. dr. E. Fliers, Academic Medical Center, University of Amsterdam

相似试验

The effect of lanreotide on non-functioning... | 临床试验